A detailed history of Fmr LLC transactions in Simulations Plus, Inc. stock. As of the latest transaction made, Fmr LLC holds 2,484 shares of SLP stock, worth $77,550. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,484
Previous 1,616 53.71%
Holding current value
$77,550
Previous $66,000 81.82%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$38.46 - $50.95 $33,383 - $44,224
868 Added 53.71%
2,484 $120,000
Q1 2024

May 13, 2024

BUY
$37.48 - $44.74 $14,654 - $17,493
391 Added 31.92%
1,616 $66,000
Q4 2023

Feb 13, 2024

SELL
$33.36 - $45.71 $12.1 Million - $16.5 Million
-361,568 Reduced 99.66%
1,225 $54,000
Q3 2023

Nov 13, 2023

SELL
$40.03 - $51.51 $214,520 - $276,042
-5,359 Reduced 1.46%
362,793 $15.1 Million
Q2 2023

Aug 11, 2023

BUY
$40.45 - $48.0 $658,000 - $780,816
16,267 Added 4.62%
368,152 $16 Million
Q1 2023

May 11, 2023

SELL
$34.96 - $43.94 $62,613 - $78,696
-1,791 Reduced 0.51%
351,885 $15.5 Million
Q4 2022

Feb 13, 2023

SELL
$36.55 - $51.15 $42,544 - $59,538
-1,164 Reduced 0.33%
353,676 $12.9 Million
Q3 2022

Nov 10, 2022

BUY
$47.75 - $66.88 $1.52 Million - $2.13 Million
31,858 Added 9.86%
354,840 $17.2 Million
Q2 2022

Aug 12, 2022

BUY
$40.55 - $51.76 $1.96 Million - $2.5 Million
48,305 Added 17.59%
322,982 $15.9 Million
Q1 2022

May 13, 2022

BUY
$36.56 - $50.98 $99,041 - $138,104
2,709 Added 1.0%
274,677 $14 Million
Q4 2021

Feb 14, 2022

SELL
$37.1 - $57.45 $89,744 - $138,971
-2,419 Reduced 0.88%
271,968 $12.9 Million
Q3 2021

Nov 15, 2021

SELL
$38.45 - $55.66 $153 - $222
-4 Reduced -0.0%
274,387 $10.8 Million
Q2 2021

Aug 13, 2021

BUY
$49.67 - $68.96 $13.6 Million - $18.9 Million
274,391 New
274,391 $15.1 Million

Others Institutions Holding SLP

About Simulations Plus, Inc.


  • Ticker SLP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 20,297,700
  • Market Cap $634M
  • Description
  • Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which sim...
More about SLP
Track This Portfolio

Track Fmr LLC Portfolio

Follow Fmr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.